This study investigates localized pancreatic cancer. It will look at how plasma ctDNA and eccDNA before surgery might predict early recurrence and survival.
The study evaluates if using plasma ctDNA with CT scans and ultrasound can improve survival compared to usual care.
- Who can participate: Adults with localized pancreatic cancer stages I-III, scheduled for surgical resection, may qualify. Participants must not have had other cancers in the last 3 years.
- Study details: Participants will have blood samples taken at specific times. In one part of the study, some will have DNA-guided surveillance.